Join
Live feed
·
INSIDERFilingvia Quantisnow
Galectin Therapeutics Inc. logo

Director Shlevin Harold H. sold $119,240 worth of shares (20,000 units at $5.96), sold $936,071 worth of shares (155,790 units at $6.01), exercised 151,790 shares at a strike of $2.31 and exercised 20,000 shares at a strike of $1.98, decreasing direct ownership by 26% to 11,206 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GALT (Galectin Therapeutics Inc.) and more on Quantisnow.